SCHEMBL24515328

SCHEMBL24515328

COC(=O)c1cnc(Cl)cc1N1CCOCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.47
MAPK1 P28482 3/20 0.46
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 4/20 0.45
GAA P10253 4/20 0.45
TSHR P16473 1/20 0.45
ATM Q13315 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ALOX15 P16050 3/20 0.44
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HCRTR1 O43613 1/20 0.43
HCRTR2 O43614 1/20 0.43
ADORA1 P30542 1/20 0.42
OPRK1 P41145 1/20 0.42
APAF1 O14727 1/20 0.42
NPC1 O15118 1/20 0.42
TDP2 O95551 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29845733 1.00 MAPT (0.47) MAPTMAPK1ALDH1A1KDM4EGAA
SCHEMBL17478733 0.90 MAPT (0.49) MAPTMAPK1ALDH1A1KDM4EGAA
SCHEMBL22717265 0.86 PKM (0.55) MAPTMAPK1ALDH1A1KDM4EGAA
SCHEMBL29574368 0.86 PKM (0.55) MAPTMAPK1ALDH1A1KDM4EGAA
SCHEMBL25153559 0.85 ALDH1A1 (0.49) MAPTMAPK1ALDH1A1KDM4EGAA
SCHEMBL22717862 0.84 CYP2C19 (0.48) MAPTMAPK1ALDH1A1KDM4EGAA
SCHEMBL22717354 0.83 POLB (0.48) MAPTALDH1A1KDM4EGAATSHR
SCHEMBL29574584 0.83 POLB (0.48) MAPTALDH1A1KDM4EGAATSHR
SCHEMBL22120919 0.83 CYP3A4 (0.40) MAPTTSHRHSD17B10OPRK1
SCHEMBL24515322 0.81 MAPT (0.43) MAPTMAPK1ALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022122987-A1 ANTHELMINTIC COMPOUNDS COMPRISING A PYRIDINE STRUCTURE INTERVET INTERNATIONAL B.V. (NL) 2022-06-16 WO disclosed